From the first protein structures to our current knowledge of protein folding: Delights and scepticisms

Nature Reviews Molecular Cell Biology

Volumn 9, Issue 8, 2008, Pages 650-654

  Fersht, Alan R ^a,b  

^a Department of Chemistry ^*  (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HELIX; BETA SHEET; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ENGINEERING; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECOMBINANT DNA TECHNOLOGY; REVIEW; X RAY CRYSTALLOGRAPHY;

ANIMALS; COMPUTER SIMULATION; GENOMICS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMAGING, THREE-DIMENSIONAL; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN FOLDING; RECOMBINANT PROTEINS;

EID: 47749083052     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2446     Document Type: Review

References (52)

1. Kendrew, J. C. et al. A three-dimensional model of the myoglobin molecule obtained by X-ray analysis. Nature 181, 662-666 (1958).
2. Perutz, M. F. et al. A three-dimensional fourier synthesis at 5.5-Å resolution, obtained by X-ray analysis. Nature 185, 416-422 (1960).
3. Blake, C. C. et al. Structure of hen egg-white lysozyme. A three-dimensional Fourier synthesis at 2 Å resolution. Nature 206, 757-761 (1965).
4. Matthews, B. W., Sigler, P. B., Henderson, R. & Blow, D. M. Three-dimensional structure of tosyl-α-chymotrypsin. Nature 214, 652-656 (1967).
5. Wyckoff, H. W. et al. The structure of ribonuclease-S at 3.5 Å resolution. J. Biol. Chem. 242, 3984-3988 (1967).
6. Lipscomb, W. N., Hartsuck, J. A., Quiocho, F. A. & Reeke, G. N. Jr. The structure of carboxypeptidase A. IX. The x-ray diffraction results in the light of the chemical sequence. Proc. Natl Acad. Sci. USA 64, 28-35 (1969).
7. Arnone, A. et al. A high resolution structure of an inhibitor complex of the extracellular nuclease of Staphylococcus aureus. I. Experimental procedures and chain tracing. J. Biol. Chem. 246, 2302-2316 (1971).
8. Perutz, M. F. Stereochemistry of cooperative effects in haemoglobin. Nature 228, 726-739 (1970).
9. Epstein, C. J., Goldberger, R. F. & Anfinsen, C. B. The genetic control of tertiary protein structure. Model systems. Cold Spring Harb. Symp. Quant. Biol. 28, 439-449 (1963).
10. Levinthal, C. in Mossbauer Spectroscopy in Biological Systems (eds Debrunner, P. et al.) 22-24 (University of Illinois Press, Urbana, Illinois, 1969).
11. Ptitsyn, O. B. Stages in the mechanism of self-organization of protein molecules. Dokl. Akad. Nauk SSSR 210, 1213-1215 (1973) (in Russian).
12. Kim, P. S. & Baldwin, R. L. Specific intermediates in the folding reactions of small proteins and the mechanism of protein folding. Annu. Rev. Biochem. 51, 459-489 (1982).
13. Karplus, M. & Weaver, D. L. Diffusion-collision model for protein folding. Biopolymers 18, 1421-1437 (1979).
14. Dolgikh, D. A. et al. α-Lactalbumin: compact state with fluctuating tertiary structure? FEBS Lett. 136, 311-315 (1981).
15. Creighton, T. E. The two-disulphide intermediates and the folding pathway of reduced pancreatic trypsin inhibitor. J. Mol. Biol. 95, 167-199 (1975).
16. Cohen, S. N., Chang, A. C., Boyer, H. W. & Helling, R. B. Construction of biologically functional bacterial plasmids in vitro. Proc. Natl Acad. Sci. USA 70, 3240-3244 (1973).
17. Shortle, D. A genetic system for analysis of staphylococcal nuclease. Gene 22, 181-189 (1983).
18. Perry, L. J., Heyneker, H. L. & Wetzel, R. Non-toxic expression in Escherichia coli of a plasmid-encoded gene for phage T4 lysozyme. Gene 38, 259-264 (1985).
19. Hartley, R. W. Barnase and barstar. Expression of its cloned inhibitor permits expression of a cloned ribonuclease. J. Mol. Biol. 202, 913-915 (1988).
20. Sanger, F. et al. Nucleotide sequence of bacteriophage φ X174 DNA. Nature 265, 687-695 (1977).
21. Hutchison, C. A., et al. Mutagenesis at a specific position in a DNA sequence. J. Biol. Chem. 253, 6551-6560 (1978).
22. Winter, G., Fersht, A. R., Wilkinson, A. J., Zoller, M. & Smith, M. Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding. Nature 299, 756-758 (1982).
23. Matouschek, A., Kellis, J. T. Jr., Serrano, L. & Fersht, A. R. Mapping the transition state and pathway of protein folding by protein engineering. Nature 340, 122-126 (1989).
24. Fersht, A. R., Leatherbarrow, R. J. & Wells, T. N. Structure-activity relationships in engineered proteins: analysis of use of binding energy by linear free energy relationships. Biochemistry 26, 6030-6038 (1987).
25. Itzhaki, L. S., Otzen, D. E. & Fersht, A. R. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding. J. Mol. Biol. 254, 260-288 (1995).
26. Daggett, V. & Fersht, A. R. Is there a unifying mechanism for protein folding? Trends Biochem. Sci. 28, 18-25 (2003).
27. Levitt, M. & Lifson, S. Refinement of protein conformations using a macromolecular energy minimization procedure. J. Mol. Biol. 46, 269-279 (1969).
28. McCammon, J. A., Gelin, B. R. & Karplus, M. Dynamics of folded proteins. Nature 267, 585-590 (1977).
29. Daggett, V. & Fersht, A. The present view of the mechanism of protein folding. Nature Rev. Mol. Cell Biol. 4, 497-502 (2003).
30. 1H nuclear magnetic resonance and distance geometry. J. Mol. Biol. 182, 295-315 (1985).
31. Baum, J., Dobson, C. M., Evans, P. A. & Hanley, C. Characterization of a partly folded protein by NMR methods: studies on the molten globule state of guinea pig α-lactalbumin. Biochemistry 28, 7-13 (1989).
32. Bax, A. & Grishaev, A. Weak alignment NMR: a hawk-eyed view of biomolecular structure. Curr. Opin. Struct. Biol. 15, 563-570 (2005).
33. Religa, T. L., Markson, J. S., Mayor, U., Freund, S. M. & Fersht, A. R. Solution structure of a protein denatured state and folding intermediate. Nature 437, 1053-1056 (2005).
34. Korzhnev, D. M. & Kay, L. E. Probing invisible, low-populated states of protein molecules by relaxation dispersion NMR spectroscopy: an application to protein folding. Acc. Chem. Res. 41, 442-451 (2008).
35. Hvidt, A. & Linderstrøm-Lang, K. Exchange of hydrogen atoms in insulin with deuterium atoms in aqueous solutions. Biochim. Biophys. Acta 14, 574-575 (1954).
36. Englander, S. W., Mayne, L., Bai, Y. & Sosnick, T. R. Hydrogen exchange: the modern legacy of Linderstrøm-Lang. Protein Sci. 6, 1101-1109 (1997).
37. Levitt, M. & Chothia, C. Structural patterns in globular proteins. Nature 261, 552-558 (1976).
38. Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
39. Petsko, G. A. An idea whose time has gone. Genome Biol. 8, 107 (2007).
40. Banci, L. et al. An idea whose time has come. Genome Biol. 8, 408 (2007).
41. Moult, J. et al. Critical assessment of methods of protein structure prediction - Round VII. Proteins 69 (Suppl. 8), 3-9 (2007).
42. Daggett, V. & Levitt, M. Protein unfolding pathways explored through molecular dynamics simulations. J. Mol. Biol. 232, 600-619 (1993).
43. Mayor, U. et al. The complete folding pathway of a protein from nanoseconds to microseconds. Nature 421, 863-867 (2003).
44. Vendruscolo, M., Paci, E., Dobson, C. M. & Karplus, M. Three key residues form a critical contact network in a protein folding transition state. Nature 409, 641-645 (2001).
45. Gianni, S. et al. Unifying features in protein-folding mechanisms. Proc. Natl Acad. Sci. USA 100, 13286-13291 (2003).
46. Fink, A. L. Natively unfolded proteins. Curr. Opin. Struct. Biol. 15, 35-41 (2005).
47. Wells, M. et al. Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Proc. Natl Acad. Sci. USA 105, 5762-5767 (2008).
48. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366 (2006).
49. Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S. & Winter, G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321, 522-525 (1986).
50. Jiang, L. et al. De novo computational design of retro-aldol enzymes. Science 319, 1387-1391 (2008).
51. Rothlisberger, D. et al. Kemp elimination catalysts by computational enzyme design. Nature 453, 190-195 (2008).
52. Maxam, A. M. & Gilbert, W. A new method for sequencing DNA. Proc. Natl Acad. Sci. USA 74, 560-564 (1977).